<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Novo Nordisk Faces Uncertainty Amid Revenue Guidance Adjustment and Leadership Transition

PremiumRatings

1d ago

Novo Nordisk Announces Executive Share Transactions

PremiumCompany Announcements

1d ago

CoreWeave reports Q2 beat, Gildan to acquire Hanesbrands: Morning Buzz

PremiumThe Fly

2d ago

DIS

PremiumThe Fly

Pfizer seeking spot in China’s private insurance catalog, Bloomberg reports

2d ago

LLY

PremiumThe FlyEli Lilly launches injector pen for Mounjaro in India, Reuters reports

2d ago

LLY

Novo Nordisk upgraded to Neutral from Underperform at BNP Paribas Exane

The Fly

Novo Nordisk upgraded to Neutral from Underperform at BNP Paribas Exane

2d ago

Company Announcements

Novo Nordisk’s NNC6019-0001 Study: A Potential Game-Changer for Heart Disease Treatment

3d ago

Novo Nordisk’s Promising Heart Failure Study: A Potential Game-Changer?

PremiumCompany Announcements

3d ago

Novo Nordisk’s Promising Diabetes Study: A Potential Game-Changer?

PremiumCompany Announcements

3d ago

Novo Nordisk’s Diabetes Study: A Potential Game-Changer for Blood Sugar Management

PremiumCompany Announcements

3d ago

Novo Nordisk’s Semaglutide Study: A New Chapter in Diabetes Treatment

PremiumCompany Announcements

3d ago

PremiumCompany AnnouncementsNovo Nordisk’s Semaglutide Study: A Potential Game-Changer for Heart Failure and Diabetes

3d ago

Company Announcements

Novo Nordisk’s Semaglutide Study: A Potential Breakthrough for Kidney Health

3d ago

Company Announcements

Novo Nordisk’s New Study on Kidney Disease Treatment: What Investors Need to Know

3d ago

Novo Nordisk’s Promising Study on Heart Failure Treatment: What Investors Need to Know

PremiumCompany Announcements

3d ago

Novo Nordisk’s Semaglutide Study: A Potential Game-Changer for Diabetic Eye Disease?

PremiumCompany Announcements

3d ago

Novo Nordisk’s Ziltivekimab Study: A Potential Game-Changer for Heart Failure Treatment

PremiumCompany Announcements

3d ago

Novo Nordisk’s New Diabetes Study: A Potential Game Changer?

PremiumCompany Announcements

3d ago

PremiumCompany AnnouncementsNovo Nordisk’s Promising Heart Failure Study: A Market Game-Changer?

3d ago

Company Announcements

Novo Nordisk’s Pediatric Diabetes Study: A Potential Game-Changer?

3d ago

Mixed options sentiment in Novo Nordisk with shares down 1.85%

The Fly

Mixed options sentiment in Novo Nordisk with shares down 1.85%

4d ago